References
Cho HJ, Lee TG, Han SY, Kim HS, Kim JH, Han JI, Lew YJ, Kim JW (2015) Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol. doi:10.1007/s00417-015-2993-3
Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D’Amore PA (2009) An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A 106(44):18751–18756
Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, D’Amore PA (2008) VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med 205:491–501
Ambati J, Ambati B, Yoo S, Ianchulev S, Adamis A (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257–293
Grunwald JE, Pistilli M, Ying GS, Maguire MG, Daniel E, Martin DF (2015) Comparison of age-related macular degeneration treatments trials research group. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122(4):809–816
Grunwald JE, Daniel E, Huang J, Ying GS, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B, Klein ML, Martin AA, Hagstrom SA, Martin DF, CATT Research Group (2014) Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121(1):150–161
Kim JH, Kim JR, Kang SW, Kim SJ, Ha HS (2013) Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration. Am J Ophthalmol 155:743–749
Acknowledgments
Each author warrants that he has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article. Furthermore, our research was not funded from any of the following organizations: National Institutes of Health (NIH); Howard Hughes Medical Institute (HHMI); and other(s).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cakir, A., Duzgun, E. Re: Cho et al. “Long-term visual outcome and prognostic factors of intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation”. Graefes Arch Clin Exp Ophthalmol 254, 1425–1426 (2016). https://doi.org/10.1007/s00417-016-3268-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3268-3